Cysteine S-conjugates activate transcription factor NF-κB in cultured renal epithelial cells

American Journal of Physiology - Renal Physiology

Volumn 273, Issue 1 42-1, 1997, Pages

  Otieno, Monicah A ^a,b   Anders, M W ^a,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Antioxidants; Cytotoxicity; LLC PK1 cells; Oxidative stress; S (1,2 dichlorovinyl) L cysteine; lyase

Indexed keywords

ACETYLCYSTEINE; AMINOOXYACETIC ACID; CYSTEINE CONJUGATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; N,N' DIPHENYL 1,4 PHENYLENEDIAMINE; NUCLEAR PROTEIN; OLIGONUCLEOTIDE; STAUROSPORINE;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; ELECTROPHORETIC MOBILITY; ENHANCER REGION; GENETIC TRANSFECTION; KIDNEY EPITHELIUM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; SECOND MESSENGER; SWINE;

EID: 0030771403     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Alkalay, I., A. Yaron, A. Hatzubai, A. Orian, A. Ciechanover, and Y. Ben-Neriah. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteosome pathway. Proc. Natl. Acad. Sci. USA 92: 10599-10603, 1995.
2. Anders, M. W., W. Dekant, and S. Vamvakas. Glutathione-dependent bioactivation of xenobiotics. In: Biothiols, edited by L. Packer and E. Cadenas. New York: Dekker, 1995, p. 135-163.
3. Baeuerle, P. A., and T. Henkel. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179, 1994.
4. Beg, A. A., and A. S. Baldwin, Jr. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev. 7: 2064-2070, 1993.
5. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90: 2532-2536, 1993.
6. Chen, Q., K. Yu, N. J. Holbrook, and J. L. Stevens. Activation of the growth arrest and DNA damage-inducible gene gadd by nephrotoxic cysteine conjugates and dithiothreitol. J. Biol. Chem. 267: 8207-8212, 1992.
7. Das, K. C., Y. Lewis-Molock, and C. W. White. Activation of NF-κB and elevation of MnSOD gene expression by thiol reducing agents in lung adenocarcinoma (A549) cells. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L588-L602, 1995.
8. Dekant, W., S. Vamvakas, and M. W. Anders. Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates: Cysteine conjugate β-lyase pathway. Adv. Pharmacol. 27: 115-162, 1994.
9. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489, 1983.
10. Duyao, M. P., A. J. Buckler, and G. E. Sonenshein. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87: 4727-4731, 1990.
11. Elfarra, A. A., I. Jakobson, and M. W. Anders. Mechanism of S-(1,2-dichlorovinyl)glutathione-induced nephrotoxicity. Biochem. Pharmacol. 35: 283-288, 1986.
12. Henkel, T., T. Machleidt, I. Alkalay, M. Krönke, Y. Ben-Neriah, and P. A. Baeuerle. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365: 182-185, 1993.
13. Israël, A., O. Le Bail, K. Hatat, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky. TNF stimulates expression of mouse MHC class I genes by inducing an NFκB-like enhancer binding activity which displaces constitutive factors. EMBO J. 8: 3793-3800, 1989.
14. Jones, P. L., G. Kucera, H. Gordon, and J. M. Boss. Cloning and characterization of the murine manganous superoxide dismutase-encoding gene. Gene 153: 155-161, 1995.
15. Li, C.-C., R.-M. Dai, and D. L. Longo. Inactivation of NF-κB inhibitor IκBα: ubiquitin-dependent proteolysis and its degradation product. Biochem. Biophys. Res. Commun. 215: 292-301, 1995.
16. Littlewood, T. D., and G. I. Evans. The role of myc oncogenes in cell growth and differentiation. Adv. Dental Res. 4: 69-79, 1990.
17. Matsumoto, H., and Y. Sasaki. Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 158: 105-109, 1989.
18. McKinney, L. L., J. C. Picken, Jr., F. B. Weakley, A. C. Eldridge, R. E. Campbell, J. C. Cowan, and H. E. Biester. Possible toxic factor of trichloroethylene-extracted soybean oil meal. J. Am. Chem. Soc. 81: 909-915, 1959.
19. Meichle, A., S. Schultze, G. Hensel, D. Brunsing, and M. Kronke. Protein kinase C-independent activation of nuclear factor κB by tumor necrosis factor. J. Biol. Chem. 265: 8339-8343, 1990.
20. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12: 2005-2015, 1993.
21. Miyamoto, S., and I. M. Verma. REL/NF-κB/IκB Story. Adv. Cancer Res. 66: 255-292, 1995.
22. Muñoz, E., G. Courtois, P. Veschambre, P. Jalinot, and A, Israël. Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of IκBα/MAD3. J. Virol. 68: 8035-8044, 1994.
23. Pang, X.-P., N. S. Ross, M. Park, G. J. F. Juillard, T. M. Stanley, and J. M. Hershman. Tumor necrosis factor-α activates nuclear factor κB and induces manganous superoxide dismutase and phosphodiesterase mRNA in human papillary thyroid carcinoma cells. J. Biol. Chem. 267: 12826-12830, 1992.
24. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. Signal-induced degradation of IκBα requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92: 11259-11263, 1995.
25. Schreck, R., P. Rieber, and P. A. Baeuerle. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10: 2247-2258, 1991.
26. Sun, S.-C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915, 1993.
27. Thanos, D., and T. Maniatis. NF-κB: a lesson in family values. Cell 80: 529-532, 1995.
28. Vamvakas, S., and U. Köster. The nephrotoxin dichlorovinylcysteine induces expression of the protooncogenes c-fos and c-myc in LLC-PK1 cells-A comparative investigation with growth factors and 12-O-tetradecanoylphorholacetate. Cell Biol. Toxicol. 9: 1-13, 1993.
29. Vamvakas, S., H. Richter, and D. Bittner. Induction of dedifferentiated clones of LLC-PK1 cells upon long-term exposure to dichlorovinylcysteine. Toxicology 106: 65-74, 1996.
30. Xia, C., J. Hu, B. Ketterer, and J. B. Taylor. The organization of the human GSTP-1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem. J. 313: 155-161, 1996.
31. Yu, K., Q. Chen, H. Liu, Y. Zhan, and J. L. Stevens. Signalling the molecular stress response to nephrotoxic and mutagenic cysteine conjugates: Differential roles for protein synthesis and calcium in the induction of c-fos and c-myc mRNA in LLC-PK1 cells. J. Cell. Physiol. 161: 303-311, 1994.